What We Do

Our Financial Advisory Practice supports investors & client companies engaged in major capital decisions with independent and objective services. We provide deep content knowledge in life sciences, diagnostics and devices markets complemented by proven financial expertise to help our clients through buy-side and sell-side support, internal strategic decision-support and independent opinion services.

Our team has supported transactions and/or strategic business decisions valued at over $400B, and we have completed over 1,000 projects. Our business is global, and we support assets at every phase of development, from multibillion-dollar business units to early-stage intellectual property.

We support equity, debt & royalty deals and provide general valuation services. Our approach is reliable, transparent and evidence-based. Our due diligence efforts utilize Foster|Rosenblatt’s core competency in characterizing markets and accurately forecasting future product performance.

Bloomberg

Foster|Rosenblatt exclusively provides the life sciences market and epidemiology models for the Bloomberg Terminal. Our work is an important research tool for stakeholders who require current landscape data and forward-looking analyses of high-value therapeutic areas.

White Paper

Valuing Early-Stage Pharma Assets with Discrete Discount Aggregation

Market Assessment & Forecasting

We characterize markets with precision and a forward-looking perspective. Our analysts understand the market landscape in today’s terms with all its moving parts, opportunities and risks, and we are able to accurately predict the likely future performance range for markets/products. Our work incorporates the each of the key influences on markets. This includes discrete understanding of the scientific, clinical, regulatory, customer demand, pricing/access, competitive intensity, commercial model, promotion and public policy impacts on product utilization and value.

We conduct & interpret market research to deeply understand and quantify opportunity & risk. We field qualitative and quantitative primary market research. Our interviews are moderated by our internal industry experts. Our quant work is designed for reliability, generalizability & validity. We specialize in discrete choice & conjoint methods. Our secondary desk research utilizes a wide array of sources that include in-house market sales data, proprietary industry reports, clinical trial data, epidemiology & census data, analyst reports, published literature, press releases and public filings.

We have a dedicated advanced modeling team that utilize our research and insights to evolve market uncertainty into quantifiable opportunity and risk. These functionally advanced predictive models may be deterministic, systems or probabilistic.

Valuation Advisory

We prepare defensible valuations and associated opinions using our deep industry knowledge and financial expertise. Our methods address the unique needs of assets at every stage of the life cycle. Our valuations support access to capital markets, tax reporting and financial reporting.

Asset Types

  • Intellectual property
  • Drugs / therapeutics
  • Medical devices
  • Imaging diagnostics
  • Molecular & other diagnostics
  • Business units
  • Companies

Use Cases

  • Fund Valuation Reporting - Meeting the regulatory and fiduciary needs of fund managers
  • Licensing Transactions - Providing valuations, diligence and deal support for sensitive market segments
  • Private Financings - Ensuring risks are well characterized & value is clearly demonstrated
  • M&A - Delivering independent & objective valuations for all parties
  • IPO - Providing valuations that support all parties in the IPO process

Transaction Support

We work with the buy-side & sell-side and with lenders & borrowers. We are with our clients at every step of the way on an “as needed” basis or as a standing member of their team.

We conduct commercial diligence that informs our clients’ investment decisions. We design evaluative decision-frameworks and deliver evidence-based analyses that fully characterize a target’s market opportunity. Our work frames a potential acquisition for well-structured ownership and eventually, an efficient exit. Among other considerations, our diligence focuses on these factors:

Commercial Diligence

  • Market definition
  • Strength of asset
  • Market attractiveness
  • Competitive position
  • Customer insights
  • Pricing & market access
  • Promotion & sales
  • Critical success factors
  • Synergy assessment
  • Forecasts
  • Scenario plans
  • Business planning
  • Collateral assessment & likely buyer identification

Risk Quantification

  • Scientific
  • Clinical
  • Regulatory
  • Commercial
  • Competitive
  • Policy

Opinions

Fairness Opinions: We help boards of directors, special committees, companies, and business owners fulfill their fiduciary duties by providing them with comprehensive analyses and unbiased opinions about the financial fairness of pending transactions.

Fund Opinions: We assist financial sponsors, including private equity funds, hedge funds and credit funds, through a range of affiliate transactions.

Valuation Opinions: Our valuation professionals combine analytical tools with real-world transaction experience to objectively determine corporate worth. We help our clients determine their enterprise value in a variety of situations.

Strategic Advisory

Foster|Rosenblatt provides advisory services that cover commercial strategy, capital options and tactical execution.

Opportunity Assessment

We help you assess every prospect with our internal industry expertise (buy-side, sell-side, borrower & lender).

Strategic Growth

We work with you to identify the highest & best use of your capital, intellectual property & capabilities.

Competitive Landscape

We provide comprehensive understanding of the current & projected competitive business environment.

Management Support

We work with pre-commercial companies to navigate the transition from scientific to commercial focus.

Boards & Special Committees

We work with these committees to provide facts, insights and crisp recommendations

Turnaround Expertise

We work with financial sponsors to design & execute turnaround strategies for independent or portfolio companies

Target Selection

We screen target companies against clearly defined criteria tied to overall deal goals

Structuring

We develop strategic-level deal structuring reflecting the current & projected business environment

Our Experience

Foster|Rosenblatt has supported transactions and/or strategic business decisions for assets associated with these companies(partial list)

 

Foster|Rosenblatt has experience in every major market &
can begin each client engagement with an immediately applicable skill set

  • Cardiology/Vascular
  • Dental & Oral Health
  • Dermatology
  • Devices
  • Diagnostics
  • Digital Healthcare
  • Endocrinology
  • Family Medicine
  • Gastroenterology
  • Genetic Disease
  • Hematology (Benign)
  • Hematology (Malignant)
  • Hepatology
  • Imaging
  • Immunology
  • Infectious Diseases
  • Internal Medicine
  • Internet of Medical Things
  • Musculoskeletal
  • Nephrology Neurology
  • Nutrition & Weight Loss
  • Obstetrics & Gynecology
  • Oncology
  • Ophthalmology
  • Orthopedics & Ortho
  • Otolaryngology
  • Pediatrics & Neonatology
  • Podiatry
  • Psychiatry & Psychology
  • Pulmonary & Respiratory
  • Rare Diseases & Disorders
  • Rheumatology
  • Sleep Disorders
  • Trauma
  • Urology
  • Vaccines
  • 3-D Printing
  • Foster|Rosenblatt